Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Ubiquitination/ Proteasome

Items 11-20 of 85

Page
per page
  1. HMB-Val-Ser-Leu-VE
    C4090 HMB-Val-Ser-Leu-VE
    Summary: inhibitor of the trypsin-like activity of the 20S proteasome
      ≤20 mg/mL
  2. Divalproex Sodium
    B1391 Divalproex Sodium
    Summary: Epilepsy/migraines/bipolar disorder medicine
      ≥14.2 mg/mL
  3. SAR405
    A8883 SAR405
     22 Citation
    Summary: Selective ATP-competitive inhibitor of Vps34
      ≥22.19 mg/mL
  4. VR23
    B6026 VR23
    Target: Proteasome
    Summary: proteasome inhibitor
      insoluble in EtOH; insoluble in H2O; ≥45.55 mg/mL
  5. PI-1840
    B4755 PI-1840
    Summary: Chymotrypsin-like (CT-L) inhibitor
  6. LY3009120
    A8716 LY3009120
    Target: Raf
    Summary: pan-RAF and RAF dimer inhibitor
      insoluble in H2O; insoluble in EtOH; ≥4.25 mg/mL
  7. SBI-0206965
    A8715 SBI-0206965
     2 Citation
    Target: ULK1
    Summary: ULK1 inhibitor
      ≥24.47 mg/mL
  8. MG-262
    A8179 MG-262
     2 Citation
    Target: Proteasome
    Summary: Proteasome inhibitor
      ≥24.57 mg/mL
  9. Concanamycin A
    A8633 Concanamycin A
     1 Citation
    Target: Vacuolar-type ATPase
    Summary: V-type (vacuolar) H+-ATPase inhibitor
      soluble in DMSO
  10. Dihydroeponemycin
    A8172 Dihydroeponemycin
     1 Citation
    Summary: Proteasome inhibitor,antitumor reagent,eponemycin ddrivative
      ≥15.6 mg/mL

Items 11-20 of 85

Page
per page